Log in to your Inderes Free account to see all free content on this page.
aXichem
1.50 SEK
-2.28 %
Less than 1K followers
AXIC A
First North Stockholm
Chemicals
Basic Materials
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-2.28 %
+9.49 %
+13.21 %
-27.01 %
-38.33 %
-44.04 %
-77.10 %
-94.92 %
-91.05 %
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.
Read moreMarket cap
101.59M SEK
Turnover
27.22K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17.6.
2026
General meeting '26
27.8.
2026
Interim report Q2'26
26.11.
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio